01-06-2025
Jefferies Reaffirms Their Sell Rating on Rohto Pharmaceutical Co (RPHCF)
In a report released on May 29, Hisae Kawamoto from Jefferies maintained a Sell rating on Rohto Pharmaceutical Co (RPHCF – Research Report), with a price target of Yen1,750.00.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Kawamoto covers the Consumer Defensive sector, focusing on stocks such as Shiseido Company,Limited, Pigeon Corporation, and Kao. According to TipRanks, Kawamoto has an average return of -0.7% and a 42.11% success rate on recommended stocks.
Rohto Pharmaceutical Co has an analyst consensus of Moderate Buy, with a price target consensus of $17.96.
